Group Also Asks Merck CEO His View of Obama Medicare Plan that Eli Lilly CEO Says Would Lower Private Investment in New Drug Research by $15 Billion Annually Bridgewater, NJ / Washington, D.C. – At today’s annual meeting of Merck shareholders in Bridgewater, New Jersey, … Continue reading Free-Market Group Presents Shareholder Proposal to Merck Asking Company to Come Clean on Lobbying Goals and Expenses in Light of Company’s Support for Passage of ObamaCare